News
New findings reveal Syfovre may protect central vision in macular degeneration patients, delaying vision loss and enhancing treatment strategies.
Alcon launched Tryptyr, a treatment for the signs and symptoms of dry eye disease, in the U.S. Tryptyr (acoltremon ophthalmic solution 0.003%) is a TRPM8 receptor agonist that showed a “statistically ...
With integrated clinical, lab, and research teams onsite, BostonSight expands its capacity to support trials advancing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results